Bioabsorbable coronary stents - should they be buried?
作者信息
Ellis Stephen G
机构信息
Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA.
出版信息
EuroIntervention. 2022 Mar 18;17(16):1286-1287. doi: 10.4244/EIJ-E-21-00012.
Abstract
摘要
相似文献
1
Bioabsorbable coronary stents - should they be buried?生物可吸收冠状动脉支架——它们应该被摒弃吗？
EuroIntervention. 2022 Mar 18;17(16):1286-1287. doi: 10.4244/EIJ-E-21-00012.
2
Difference of vascular healing between bioabsorbable-polymer and durable-polymer new generation drug-eluting stents: an optical coherence tomographic analysis.新一代生物可吸收聚合物和永久性聚合物药物洗脱支架血管愈合的差异：光学相干断层成像分析。
Int J Cardiovasc Imaging. 2021 Apr;37(4):1131-1141. doi: 10.1007/s10554-020-02094-y. Epub 2020 Nov 9.
3
Stents for coronary artery disease: from covered to drug-eluting to bioabsorbable ..
Hellenic J Cardiol. 2012 Jan-Feb;53(1):89-90.
4
Culotte stenting with bioabsorbable everolimus-eluting stents.使用生物可吸收依维莫司洗脱支架的裤裙式支架置入术。
Int J Cardiol. 2013 Sep 30;168(2):e35-7. doi: 10.1016/j.ijcard.2013.05.026. Epub 2013 Jun 2.
5
Bioabsorbable Stents: A Solution in Search of a Problem?生物可吸收支架：在寻找问题的解决方案？
JACC Cardiovasc Interv. 2017 Sep 25;10(18):1852-1854. doi: 10.1016/j.jcin.2017.07.015. Epub 2017 Aug 30.
6
Bioabsorbable Drug-Eluting Stent Versus Bare Metal Stent in Iliac Artery Evaluated by Optical Coherence Tomography: An In Vivo Study in Porcine.光学相干断层扫描评估生物可吸收药物洗脱支架与裸金属支架在猪髂动脉中的应用：一项体内研究
Vasc Endovascular Surg. 2018 Oct;52(7):512-519. doi: 10.1177/1538574418783528. Epub 2018 Jul 16.
7
Thrombogenicity and early vascular healing response in metallic biodegradable polymer-based and fully bioabsorbable drug-eluting stents.基于金属可生物降解聚合物和完全可生物吸收的药物洗脱支架的血栓形成性和早期血管愈合反应
Circ Cardiovasc Interv. 2015 Jun;8(6):e002427. doi: 10.1161/CIRCINTERVENTIONS.115.002427.
8
The role of drug-eluting stents for the treatment of coronary chronic total occlusions.药物洗脱支架在冠状动脉慢性完全闭塞病变治疗中的作用。
Expert Rev Cardiovasc Ther. 2013 Oct;11(10):1349-58. doi: 10.1586/14779072.2013.838142.
9
Bioabsorbable-polymer drug-eluting stents in acute myocardial infarction: Insights from the ULLISE registry.生物可吸收聚合物药物洗脱支架治疗急性心肌梗死：来自 ULLISE 注册研究的观察。
Catheter Cardiovasc Interv. 2020 Apr 1;95(5):E144-E145. doi: 10.1002/ccd.28689.
10
Combination of the endoscopic septonasal flap technique and bioabsorbable steroid-eluting stents for repair of congenital choanal atresia in neonates and infants: a retrospective study.内镜鼻中隔瓣技术联合可吸收类固醇洗脱支架治疗新生儿和婴儿先天性后鼻孔闭锁：一项回顾性研究。
J Otolaryngol Head Neck Surg. 2021 Aug 12;50(1):51. doi: 10.1186/s40463-021-00535-9.
本文引用的文献
1
Long-term outcomes after treatment of in-stent restenosis using the Absorb everolimus-eluting bioresorbable scaffold.采用 Absorb 依维莫司洗脱生物可吸收支架治疗支架内再狭窄的长期结果。
Open Heart. 2021 Sep;8(2). doi: 10.1136/openhrt-2021-001776.
2
Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial.依维莫司洗脱生物可吸收支架与依维莫司洗脱支架的长期临床结果：AIDA 随机临床试验的最终 5 年结果。
EuroIntervention. 2022 Mar 18;17(16):1340-1347. doi: 10.4244/EIJ-D-21-00419.
3
Current perspectives on bioresorbable scaffolds in coronary intervention and other fields.当前对冠状动脉介入治疗及其他领域中生物可吸收支架的观点。
Expert Rev Med Devices. 2021 Apr;18(4):351-365. doi: 10.1080/17434440.2021.1904894. Epub 2021 Mar 30.
4
Coronary Intravascular Brachytherapy for Recurrent Coronary Drug-Eluting Stent In-Stent Restenosis: A Systematic Review and Meta-Analysis.冠状动脉血管内放射治疗复发性冠状动脉药物洗脱支架内再狭窄：系统评价和荟萃分析。
Cardiovasc Revasc Med. 2021 Feb;23:28-35. doi: 10.1016/j.carrev.2020.08.035. Epub 2020 Aug 23.
5
Time-Varying Outcomes With the Absorb Bioresorbable Vascular Scaffold During 5-Year Follow-up: A Systematic Meta-analysis and Individual Patient Data Pooled Study.5 年随访期间 Absorb 生物可吸收血管支架的时变结果：系统评价和个体患者数据合并研究。
JAMA Cardiol. 2019 Dec 1;4(12):1261-1269. doi: 10.1001/jamacardio.2019.4101.
6
Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients.血管内影像引导与冠状动脉造影引导经皮冠状动脉介入治疗伴支架植入的临床结局：31 项研究和 17882 例患者的系统评价和贝叶斯网络荟萃分析。
JACC Cardiovasc Interv. 2017 Dec 26;10(24):2488-2498. doi: 10.1016/j.jcin.2017.08.051. Epub 2017 Nov 15.
7
Bioresorbable Vascular Scaffolds for Patients With In-Stent Restenosis: The RIBS VI Study.生物可吸收血管支架治疗支架内再狭窄患者：RIBS VI 研究。
JACC Cardiovasc Interv. 2017 Sep 25;10(18):1841-1851. doi: 10.1016/j.jcin.2017.06.064. Epub 2017 Aug 30.
8
Intracoronary Brachytherapy for Recurrent Drug-Eluting Stent Failure.冠状动脉内放射治疗复发性药物洗脱支架失败。
JACC Cardiovasc Interv. 2016 Jun 27;9(12):1259-1265. doi: 10.1016/j.jcin.2016.03.018. Epub 2016 Jun 20.
9
Very Late Thrombosis After Bioresorbable Scaffolds: Cause for Concern?生物可吸收支架植入后的极晚期血栓形成：值得关注吗？
J Am Coll Cardiol. 2015 Oct 27;66(17):1915-7. doi: 10.1016/j.jacc.2015.08.863.
10
Drug-Coated Balloons Versus Second-Generation Drug-Eluting Stents for the Management of Recurrent Multimetal-Layered In-Stent Restenosis.药物涂层球囊与第二代药物洗脱支架治疗复发性多层药物洗脱支架内再狭窄。
JACC Cardiovasc Interv. 2015 Oct;8(12):1586-94. doi: 10.1016/j.jcin.2015.04.032. Epub 2015 Sep 17.
Zotero 插件